Evidence map›Paper›PMID 22130828›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2012

Isolation and characterization of human fetal myoblasts.

Ariya D Lapan, Emanuela Gussoni

Open access · greenAbstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Truncating Variant inFrontiers in genetics · 2019
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  9. Article
  10. Article
  11. Article
  12. Fam65b is important for formation of the HDAC6-dysferlin protein complex during myogenic cell differentiation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2014
    Article
  13. Article
  14. Substrate stiffness affects skeletal myoblast differentiationScience and technology of advanced materials · 2012
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Ariya D LapanBiological and Biomedical Sciences, Harvard Medical School, Boston, MA, USA.
Emanuela Gussoni
Boston Children's Hospital · USHarvard University · US

Funding

Progenitor Cells inHuman Skeletal MuscleP50NS040828 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI KUNKEL, LOUIS M · 2008 to 2011
$5.9M
SP cells and downstream progenitors in human and mouse muscleR01NS047727 · NINDS · CHILDREN'S HOSPITAL BOSTON · PI GUSSONI, EMANUELA · 2004 to 2013
$2.9M
NINDS NIH HHS 2R01NS047727NINDS NIH HHS 5P50NS040828NINDS NIH HHS P50 NS040828NINDS NIH HHS R01 NS047727
6 · The paper itself

Abstract

Dissociated human fetal skeletal muscle contains myogenic cells, as well as non-myogenic cells such as adipocytes, fibroblasts, and lymphocytes. It is therefore important to determine an efficient and reliable isolation method to obtain a purer population of myoblasts. Toward this end, fluorescence-activated cell sorting in conjunction with robust myogenic cell surface markers can be utilized to enrich for myoblasts in dissociated muscle. In this chapter, we describe a method to significantly enrich for myoblasts using -melanoma cell adhesion molecule (MCAM), which we have determined to be an excellent marker of human fetal myoblasts. The myoblasts resulting from this isolation method can then be expanded in vitro and still retain significant myogenic activity as shown by an in vitro fusion assay. The ability to isolate a highly myogenic population from dissociated muscle facilitates the in vitro study of skeletal muscle development and muscle diseases. Furthermore, robust expansion of these cells will lead to new insights in the development of cell-based therapies for human muscle disorders.

Indexed as

CD146 AntigenCells, CulturedCell SeparationFetusFlow CytometryHumansMyoblasts, SkeletalPrimary Cell CultureCD146 Antigen

Identifiers

PMID22130828
PMCPMC3249651
OpenAlexW78857381

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.